| Trial registration number
|
NCT04979923 |
Full text link
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04979923
|
First author
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
sairah s sadaf, FCPS
|
Contact
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
sairahbabar@live.com
|
Registration date
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
2021-07-28
|
Recruitment status
Last imported at : July 4, 2023, 8 p.m.
Source : ClinicalTrials.gov
|
Unknown
|
Study design
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
inclusion criteria:
- covid-19 positive
- moderate to severe ards
|
Exclusion criteria
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
- patients with copd or taking bronchodilators and steroids for chronic respiratory
illnesses
|
Number of arms
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
3
|
Funding
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Sheikh Zayed Medical College
|
Inclusion age min
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
70
|
Countries
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Pakistan
|
Type of patients
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
81
|
primary outcome
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Cough suppression
|
Notes
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
Phase 1
|
Arms
Last imported at : July 29, 2021, noon
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 733, "treatment_name": "Lidocaine", "treatment_type": "Central nervous system agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1829, "treatment_name": "Beclomethasone+salbutamol", "treatment_type": "Corticosteroids+respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1811, "treatment_name": "Salbutamol", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}]
|